Furthermore, our observations suggested that SMJF Granule might ameliorate cerebral ischemia–reperfusion injury by modulating key targets such as HIF-1α, IL-6, and NF-κB1, which are enriched in the HIF-1 signaling pathway. The gene discussed is HIF1A; the disease is brain ischemia.